Aquaculture medicines: prescribe, dispense, trace

An aquaculture prescription is not merely a product name and a dose. It connects a defined health problem, an identifiable group of animals, actual farm conditions, a medicine that can legally and clinically be used, and a traceable route through to the end of the withdrawal period. That chain protects animal welfare, treatment efficacy, food safety and the environment. It matters especially when a whole fish group is exposed through feed or water.

The European Union provides a useful worked example because its veterinary-medicines and medicated-feed regulations set explicit requirements. France adds a structured permanent herd-health mechanism that includes an annual farm health assessment and a care protocol. Readers elsewhere should use the same decision points while checking the prescribing, dispensing, residue and record rules in their own jurisdiction.

Start with the health problem, not the medicine cabinet

Regulation (EU) 2019/6 (French summary) requires a veterinary prescription to follow a clinical examination or another proper assessment of the health status of the animal or group. For medicated feed, Regulation (EU) 2019/4 (French summary) normally requires a diagnosed disease following clinical examination or another proper health assessment, with limited exceptions for certain immunological or non-antimicrobial antiparasitic products.

The assessment brings together signs, mortality, feed intake, water temperature, oxygen, recent farm events and previous disease history. Post-mortem examination, sampling, culture or antimicrobial susceptibility testing may be needed. Starting empirical treatment before collecting useful specimens can reduce diagnostic yield and make a later failure harder to explain.

The correct first decision may be not to prescribe. Low oxygen, poor water quality or a viral disease is not corrected by an antibiotic. Husbandry and biosecurity measures remain essential when they address the cause.

A farm health plan must remain operational

France’s “bilan sanitaire d’élevage” offers a practical model for systematic oversight. During a planned on-farm visit with animals present, the veterinarian establishes a reference health status from clinical, laboratory, post-mortem, production and farm-record information. The assessment identifies conditions already encountered, ranks priorities and is updated at least annually.

The veterinarian then prepares a farm-specific care protocol with the farmer. It sets non-medicinal health measures, recognised conditions for which treatment may be prescribed without a new examination in defined circumstances, instructions for implementation, information the farm must report and alert thresholds that trigger a veterinary visit. A new condition or an exceeded alert threshold requires clinical examination before prescribing.

This route depends on permanent veterinary oversight: a designated veterinarian, regular follow-up visits and regular provision of care are required in addition to the documents. The assessment and protocol are signed, included in the farm register, reviewed at least annually and retained for five years. They are not a standing prescription and do not authorise automatic repetition of last year’s treatment.

Names differ between countries, but the safeguard is similar: the veterinarian needs current knowledge of the operation, and the producer needs explicit action and escalation rules. A form alone cannot provide that control.

Authorised use comes before exceptional use

The EU default is to use a veterinary medicine according to its marketing authorisation: target species, indication, dose, route, duration, contraindications and withdrawal period. The official product information should be checked at the time of prescribing. Shared active ingredients do not make formulations interchangeable; concentration, excipients, stability and authorised conditions can differ.

Where no authorised medicine is available for a food-producing aquatic species and indication, Article 114 of Regulation 2019/6 establishes an exceptional sequence of options under the veterinarian’s direct personal responsibility. Often called the prescribing cascade, it gives priority to veterinary medicines authorised for food-producing aquatic species before tightly controlled alternatives are considered. It is not a menu from which a producer can select, and pharmacologically active substances remain subject to the EU residue framework.

International readers should resist copying the EU cascade into local practice. Availability, import pathways, compounding rules and permitted substances vary. A product mentioned in a paper or authorised for ornamental fish is not automatically lawful for food fish.

Antimicrobial decisions require a written rationale

Regulation 2019/6 prohibits routine antimicrobial use and their use to compensate for poor hygiene, inadequate husbandry, lack of care or poor farm management. Prophylaxis is restricted to exceptional situations; metaphylaxis is allowed only when the risk of spread within a group is high and no appropriate alternatives are available. An EU antimicrobial prescription is valid for five days from issue.

The case record should explain the diagnosis, group affected, relevant susceptibility evidence, alternatives considered and response plan. With oral treatment, nominal biomass and feed allocation do not guarantee exposure. Sick fish may stop eating, distribution can be uneven and dominant individuals may consume more. The medicated-feed regulation therefore requires the daily dose to be incorporated into enough feed to ensure uptake by target animals while accounting for reduced intake. Medicated feed containing antimicrobials must not be used prophylactically.

Monitoring should include intake, mortality, signs, water conditions and adverse events. Failure should prompt reassessment of diagnosis, exposure, susceptibility and delivery rather than automatic extension.

Withdrawal periods are part of treatment design

For food fish, the withdrawal period runs from the last administration until animals can enter the food chain. It belongs to the identified group and must be recorded even when it is zero. Authorised use follows the product information. Exceptional use under the EU cascade requires the veterinarian to establish a withdrawal period using Article 115.

For aquatic species producing meat, the EU calculation uses degree-days. Depending on the product’s authorisation, Article 115 provides routes including the longest aquatic withdrawal period multiplied by 1.5; the longest food-producing terrestrial period multiplied by 50 and expressed as degree-days, capped at 500; or default values of 500 or 25 degree-days in specified circumstances. Degree-days accumulate daily water temperature. They are not a fixed number of calendar days, so temperature records are essential and harvest release must not be brought forward.

This principle travels beyond the EU even where the formula differs: the residue decision must be made before treatment, linked to the actual group, and translated into an operational release date using the rule required by the competent authority.

Dispensing and farm records must form one chain

An EU prescription includes sufficient information to identify the veterinarian, keeper, animals, diagnosis or indication, medicine, pharmaceutical form and strength, quantity, dosage regimen, route, treatment duration and withdrawal period. National law determines who may dispense and adds operational requirements. Transport and storage must preserve the medicine, and the person administering it needs the prescription and product instructions.

Medicated feed adds controls over manufacture, cross-contamination, use only in the animals named by the prescription and disposal of expired material. Feed left after treatment is not a general farm stock. Nor should medicine remaining from one group be redirected to another without a new veterinary decision.

For food-producing animals, Regulation 2019/6 requires records of first administration, product, quantity, supplier, proof of acquisition, animal or group identification, prescriber, withdrawal period and treatment duration. Records must be available to the competent authority for five years. A robust aquaculture record also captures the medicine batch, dates and amounts actually delivered, daily temperature, feed intake, spills or interruptions, observed response and calculated release date.

Before administration, a two-person check or preparation sheet can confirm six items: correct fish group, product, concentration, route, schedule and withdrawal date. Unused medicines and medicated feed must be stored and disposed of through the applicable route, never poured into farm water.

Make compliance generate better health decisions

High-quality prescribing begins before the prescription and ends after outcome review. The annual health assessment establishes direction; the care protocol sets actions, reporting and alerts; the prescription makes a case-specific decision; the farm record shows what actually happened. When those layers agree, the operation can learn from an episode instead of merely filing it.

Vetofish can support aquaculture operations with health-risk review, farm health planning, alert thresholds, treatment traceability and structured review of therapeutic failures. That work supports the prescribing veterinarian and local legal framework; it never turns general guidance into a prescription.